Kristensen, Lars Erik
Deodhar, Atul http://orcid.org/0000-0002-2130-1246
Leung, Ying-Ying http://orcid.org/0000-0001-8492-6342
Vranic, Ivana
Mortezavi, Mahta
Fallon, Lara
Yndestad, Arne
Kinch, Cassandra D. http://orcid.org/0000-0002-2712-1668
Gladman, Dafna D. http://orcid.org/0000-0002-9074-0592
Funding for this research was provided by:
Pfizer Inc
Article History
Received: 22 December 2023
Accepted: 8 March 2024
First Online: 2 May 2024
Declarations
:
: Lars Erik Kristensen has received grant/research support from Biogen, Janssen, Novartis, and UCB, and has received speaker’s fees and/or consultancy fees from AbbVie, Amgen, Biogen, Bristol Myers Squibb, Eli Lilly, Galapagos, Janssen, MSD, Novartis, Pfizer Inc, and UCB. Atul Deodhar has received grant/research support from AbbVie, Bristol Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, Pfizer Inc, and UCB; and consulting fees from AbbVie, Eli Lilly, Janssen, Novartis, Pfizer Inc, and UCB. Ying-Ying Leung has received speaker’s fees from and acted as a consultant for AbbVie, Eli Lilly, Janssen, Novartis, and Pfizer Inc. Ivana Vranic, Mahta Mortezavi, Lara Fallon, and Arne Yndestad are employees and shareholders of Pfizer Inc. Cassandra D. Kinch was an employee and shareholder of Pfizer Inc at the time of this work. Dafna D. Gladman has acted as a consultant for AbbVie, Amgen, Bristol Myers Squibb, Celgene, Eli Lilly, Galapagos, Gilead Sciences, Janssen, Novartis, Pfizer Inc, and UCB, and has received grants from AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer Inc, and UCB.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.